Repron Therapeutics
About:
Repron provides treatments for solid tumour cases where radical excision is not possible and metastasis or recurrence is extremely likely.
Website: https://www.reprontherapeutics.com/
Top Investors: Claris Ventures
Description:
Repron Therapeutics provides treatments for solid tumor cases where radical excision is not possible and metastasis or recurrence is extremely likely.
Total Funding Amount:
2M EUR
Headquarters Location:
Milano, Lombardia, Italy
Founded Date:
2023-01-01
Contact Email:
info(AT)reprontherapeutics.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-06-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai